Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 68 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Evaluation of the efficacy and safety of bromocriptine QR in type 2 diabetes

Ramteke Karuna Balwant, Ramanand Sunita Jaiprakash, Ramanand Jaiprakash B, Jain Suyog Subhash, Raparti Girish Tulsidas, Patwardhan Milind Hari, Murthy Mangala, Ghanghas Ravi G

Year : 2011| Volume: 15| Issue : 5 | Page no: 33-39

   This article has been cited by
1 The effect of dopamine agonists on metabolic variables in adults with type 2 diabetes: A systematic review with meta analysis and trial sequential analysis of randomized clinical trials
Ida Brandt Andersen,Mikkel Andreassen,Jesper Krogh
Diabetes, Obesity and Metabolism. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model
Mary Courtney Moore,Marta S. Smith,Larry L. Swift,Anthony H. Cincotta,Michael Ezrokhi,Nicholas Cominos,Yahong Zhang,Ben Farmer,Alan D. Cherrington
American Journal of Physiology-Endocrinology and Metabolism. 2020; 319(1): E133
[Pubmed]  [Google Scholar] [DOI]
3 Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus
Maka Siamashvili,Stephen Davis
Expert Opinion on Pharmacotherapy. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus
Stanley S. Schwartz,Farhad Zangeneh
Postgraduate Medicine. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
5 A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters
E.M. Lamos,D.L. Levitt,K.M. Munir
Primary Care Diabetes. 2016; 10(1): 60
[Pubmed]  [Google Scholar] [DOI]
6 Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases
Alexander O Shpakov,Kira V Derkach,Lev M Berstein
Future Science OA. 2015; 1(3)
[Pubmed]  [Google Scholar] [DOI]
7 Bromocriptine mesylate QR in treatment of Type 2 diabetes
George Grunberger
Diabetes Management. 2014; 4(2): 203
[Pubmed]  [Google Scholar] [DOI]
8 A review of the efficacy and safety of oral antidiabetic drugs
Stephanie Aleskow Stein,Elizabeth Mary Lamos,Stephen N Davis
Expert Opinion on Drug Safety. 2013; 12(2): 153
[Pubmed]  [Google Scholar] [DOI]


Read this article